Why Does the European Commission Prefer to Sponsor Agriculture Production Than Support Patients’ Access to Orphan Drugs?
Abstract
There is a perverse impact of external reference pricing (ERP) in orphan drugs access in Europe by comparing orphan drugs affordability in 12 European countries. This is a call for policy change in light of the fact that the EU has been able to put in place the Common Agriculture Policy (EU-CAP) in support of the agriculture sector.